XML 34 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Total
Subscription Agreements
Pre-Merger Financing
Reverse Asset Acquisition
Warrant Exercises
At-the-Market Issuance
Common Stock
Common Stock
Subscription Agreements
Common Stock
Pre-Merger Financing
Common Stock
Reverse Asset Acquisition
Common Stock
Warrant Exercises
Common Stock
At-the-Market Issuance
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Subscription Agreements
Additional Paid-in Capital
Pre-Merger Financing
Additional Paid-in Capital
Reverse Asset Acquisition
Additional Paid-in Capital
Warrant Exercises
Additional Paid-in Capital
At-the-Market Issuance
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018             4,960,552                            
Beginning balance at Dec. 31, 2018 $ (12,709,539)           $ 49,606           $ 0 $ 18,477,598           $ 451 $ (31,237,194)
Increase (Decrease) in Stockholders' Equity                                          
Stock-based compensation expense 884,089                         884,089              
Issuance of stock (in shares)               80,569 4,385,964 1,651,748 40,542,222                    
Issuance of stock   $ 1,000,000 $ 13,150,456 $ 3,565,788 $ 183,034     $ 806 $ 43,860 $ 16,517 $ 405,422       $ 999,194 $ 13,106,596 $ 3,549,271 $ (222,388)      
Conversion of debt (in shares)             1,125,673                            
Conversion of debt 13,979,788           $ 11,256             13,968,532              
Reclassification of Series B Warrants from liability to equity 11,255,740                         11,255,740              
Repurchase of treasury stock (47,864)                       (47,864)                
Foreign currency translation adjustment (451)                                     (451)  
Net loss (20,242,630)                                       (20,242,630)
Ending balance (in shares) at Dec. 31, 2019             52,746,728                            
Ending balance at Dec. 31, 2019 11,018,411           $ 527,467           (47,864) 62,018,632           0 (51,479,824)
Increase (Decrease) in Stockholders' Equity                                          
Stock-based compensation expense 660,317                         660,317              
Issuance of stock (in shares)                     1,328,405 108,137,431                  
Issuance of stock         $ 331,756 $ 36,339,786         $ 13,284 $ 1,081,375           $ 318,472 $ 35,258,411    
Conversion of debt (in shares)             21,920,820                            
Conversion of debt (4,977,876)           $ 219,208             (5,197,084)              
Foreign currency translation adjustment 0                                        
Net loss (21,821,953)                                       (21,821,953)
Ending balance (in shares) at Dec. 31, 2020             184,133,384                            
Ending balance at Dec. 31, 2020 $ 21,550,441           $ 1,841,334           $ (47,864) $ 93,058,748           $ 0 $ (73,301,777)